|Tested species reactivity||Human, Mink, Mouse, Primate, Rat|
|Published species reactivity||Human|
|Host / Isotype||Mouse / IgG2b, kappa|
|Immunogen||E1A affinity purified p300 protein|
|Storage buffer||PBS, pH 7.4, with 0.2% BSA|
|Contains||0.09% sodium azide|
|Storage Conditions||4° C|
|Tested Applications||Dilution *|
|Immunofluorescence (IF)||Assay Dependent|
|Immunohistochemistry (Paraffin) (IHC (P))||1:50-1:100|
MA5-13631 targets p300/CBP (CREB-Binding Protein) in IF and IHC (P) applications and shows reactivity with Human, Mink, mouse, Non-human primate, and Rat samples.
The MA5-13631 immunogen is e1A affinity purified p300 protein.
p300 is a transcriptional adapter protein which is characterized by three cysteine- and histidine-rich regions and its C-terminus specifically binds the adenovirus E1A protein. p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Protein kinase A mediated CREB phosphorylation results in the binding of CREB to a 265kDa nuclear protein designated CBP (for CREB-binding protein). CBP and p300 are homologous to each other.
Virus-derived platforms for visualizing protein associations inside cells.
MA5-13631 was used in immunocytochemistry to evaluate a virus-derived method for the study of protein associations inside cells
|Miller CL,Arnold MM,Broering TJ,Eichwald C,Kim J,Dinoso JB,Nibert ML||Molecular & cellular proteomics : MCP (6:1027)||2007|
KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation.
MA5-13631 was used in western blot to investigate the influence of KLF2 on endothelial inflammation
|SenBanerjee S,Lin Z,Atkins GB,Greif DM,Rao RM,Kumar A,Feinberg MW,Chen Z,Simon DI,Luscinskas FW,Michel TM,Gimbrone MA,García-Cardeña G,Jain MK||The Journal of experimental medicine (199:1305)||2004|
Expression of sex steroid receptors and their co-factors in normal and malignant breast tissue: AIB1 is a carcinoma-specific co-activator.
MA5-13631 was used in immunohistochemistry to study the expression of estrogen receptors and their transcriptional co-factors in normal and malignant breast tissue
|Hudelist G,Czerwenka K,Kubista E,Marton E,Pischinger K,Singer CF||Breast cancer research and treatment (78:193)||2003|
AW558298; CBP; CBP/p300; CREBBP; KAT3A; p300/CBP; RSTS; RTS